单孔与多孔腹腔镜远端胃切除术术后生活质量的三年随机对照随访结果
本单中心随机对照试验比较单孔与多孔腹腔镜远端胃切除术治疗临床I期胃癌的长期生活质量和体重下降率,共随机分组101例(单孔组50例、多孔组51例),术后3、6、12、36个月进行血液检查、体重测量和问卷评估。结果显示两组生活质量总体相当,单孔组部分指标更优。
要点
- 单孔组术后1、3、6、36个月中性粒细胞与淋巴细胞比值显著低于多孔组。
- 术后6个月单孔组体重下降有更低趋势,问卷评估生活质量总体相当但腹泻更少。
- 单孔腹腔镜远端胃切除术可作为I期胃癌手术的一种选择。
核心结论
- 单孔腹腔镜胃切除术在长期生活质量方面部分优于多孔腹腔镜胃切除术,并具有美观和减轻疼痛的优势。
- 单孔组全身炎症标志物和体重下降率更低,提示潜在长期获益。
- 单孔腹腔镜手术可能是I期胃癌手术的一种选择。
研究设计与样本
- 单中心随机对照试验,纳入2016年4月至2018年9月期间临床I期胃癌行远端胃切除术的患者。
- 共评估101例患者资格,随机分为单孔组(n=50)和多孔组(n=51)。
- 术后3、6、12、36个月进行血液检查、体重测量和问卷(DAUGS20、EORTC QLQ-C30、PGSAS-45)评估生活质量。
主要发现
- 术后6个月单孔组体重下降有低于多孔组的趋势。
- 术后1、3、6、36个月单孔组中性粒细胞与淋巴细胞比值显著低于多孔组。
- 问卷评估的生活质量总体相当,但单孔组部分结果更有利,如腹泻更少。
临床怎么用
- 对于临床I期胃癌需行远端胃切除术的患者,可考虑单孔腹腔镜手术作为选项。
- 单孔腹腔镜手术可能带来长期生活质量部分获益、炎症标志物更低和体重下降更少。
局限性
- 本研究为单中心随机对照试验,需进一步随访和多中心研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopic surgery for gastric cancer has become widely used; minimally invasive surgery has become the mainstream of treatment. This randomized controlled trial (RCT) aimed to compare long-term quality of life (QoL) and weight loss rates in patients who underwent single-port laparoscopic gastrectomy (SLG) or multi-port laparoscopic gastrectomy (MLG) for gastric cancer. METHODS: This single-center RCT compared MLG and SLG in patients with clinical stage I gastric cancer, all of which underwent distal gastrectomy between April 2016 and September 2018. A total of 101 patients were evaluated for eligibility; all were randomized into either the SLG group (n = 50) or MLG group (n = 51). Blood tests, weight measurements, and postoperative questionnaires (DAUGS20, EORTC QLQ-C30, PGSAS-45) were performed at 3, 6, 12, and 36 months after surgery to compare the QoL. RESULTS: At six months postoperatively, there was a higher trend toward lower weight loss in the SLG group compared with the MLG group. At 1, 3, 6, and 36 months postoperatively, the neutrophil-to-lymphocyte ratio was significantly lower in the SLG group than that in the MLG group. The QoL, as measured using the postoperative questionnaires, was generally comparable. However, some favorable results, such as fewer diarrheas, were achieved. CONCLUSIONS: SLG was partially superior to MLG in terms of long-term QoL, in addition to assurance of esthetics and reduced pain. In addition, systemic inflammatory markers and weight loss rates were lower, suggesting a potential long-term benefit. SLG may be an option for stage I gastric cancer surgery. Further follow-up and multicenter studies should be considered.
引用
- Fujita K, Omori T, Hara H, et al. Three-year follow-up outcomes of postoperative quality of life from a randomized controlled trial comparing multi-port versus single-port laparoscopic distal gastrectomy. Surg Endosc. 2024. PMID: 39528658. doi:10.1007/s00464-024-11213-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。